Therapeutic targeting of transcriptional cyclin-dependent kinases.


Journal

Transcription
ISSN: 2154-1272
Titre abrégé: Transcription
Pays: United States
ID NLM: 101530967

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 10 11 2018
medline: 2 5 2019
entrez: 10 11 2018
Statut: ppublish

Résumé

The fact that many cancer types display transcriptional addiction driven by dysregulation of oncogenic enhancers and transcription factors has led to increased interest in a group of protein kinases, known as transcriptional cyclin dependent kinases (tCDKs), as potential therapeutic targets. Despite early reservations about targeting a process that is essential to healthy cell types, there is now evidence that targeting tCDKs could provide enough therapeutic window to be effective in the clinic. Here, we discuss recent developments in this field, with an emphasis on highly-selective inhibitors and the challenges to be addressed before these inhibitors could be used for therapeutic purposes. Abbreviations: CAK: CDK-activating kinase;CDK: cyclin-dependent kinase;CMGC group: CDK-, MAPK-, GSK3-, and CLK-like;CTD: C-terminal repeat domain of the RPB1 subunit of RNA polymerase II;DRB: 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole;mCRPC: metastatic castration-resistant prostate cancer;NSCLC: non-small cell lung cancer;P-TEFb: positive elongation factor b;RNAPII: RNA polymerase II;S2: serine-2 of CTD repeats;S5: serine-5 of CTD repeats;S7: serine-7 of CTD repeats;SEC: super elongation complex;tCDK: transcriptional cyclin-dependent kinase;TNBC: triple-negative breast cancer.

Identifiants

pubmed: 30409083
doi: 10.1080/21541264.2018.1539615
pmc: PMC6602565
doi:

Substances chimiques

Antineoplastic Agents 0
Protein Kinase Inhibitors 0
Cyclin-Dependent Kinases EC 2.7.11.22

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-136

Subventions

Organisme : NCI NIH HHS
ID : R01 CA117907
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120109
Pays : United States

Références

Nature. 2000 Sep 7;407(6800):102-6
pubmed: 10993082
Genome Biol. 2001;2(10):RESEARCH0041
pubmed: 11597333
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
Gene. 2003 Mar 27;307:175-82
pubmed: 12706900
Mol Cell. 2004 Jun 4;14(5):685-91
pubmed: 15175163
BMC Genomics. 2004 Sep 20;5:69
pubmed: 15380029
J Biol Chem. 2005 Aug 5;280(31):28819-26
pubmed: 15965233
Mol Cell. 2005 Aug 19;19(4):523-34
pubmed: 16109376
J Am Chem Soc. 2006 Mar 15;128(10):3148-9
pubmed: 16522087
EMBO J. 2006 Aug 9;25(15):3596-604
pubmed: 16874302
J Biol Chem. 2007 May 11;282(19):14113-20
pubmed: 17376774
Nucleic Acids Res. 2008 Jul;36(12):3993-4008
pubmed: 18515835
Nature. 2008 Sep 25;455(7212):547-51
pubmed: 18794900
Genes Dev. 2009 Feb 15;23(4):439-51
pubmed: 19240132
Mol Cell. 2009 May 15;34(3):387-93
pubmed: 19450536
Cancer Res. 2009 Aug 1;69(15):6208-15
pubmed: 19638587
Mol Cell Biol. 2009 Oct;29(20):5455-64
pubmed: 19667075
Angew Chem Int Ed Engl. 2009;48(47):8952-7
pubmed: 19844931
Nat Struct Mol Biol. 2010 Feb;17(2):194-201
pubmed: 20098423
Mol Cell. 2010 Feb 12;37(3):429-37
pubmed: 20159561
Nature. 2010 Feb 18;463(7283):899-905
pubmed: 20164920
Cell. 2010 Apr 30;141(3):432-45
pubmed: 20434984
Genes Dev. 2010 Oct 15;24(20):2303-16
pubmed: 20952539
Nature. 2010 Dec 23;468(7327):1105-9
pubmed: 21179167
Transcription. 2010 Jul-Aug;1(1):4-12
pubmed: 21327159
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Transcription. 2011 May;2(3):115-119
pubmed: 21826281
Cell. 2011 Sep 16;146(6):904-17
pubmed: 21889194
Genes Dev. 2011 Oct 15;25(20):2158-72
pubmed: 22012619
J Genet Genomics. 2011 Oct 20;38(10):439-52
pubmed: 22035865
Annu Rev Biochem. 2012;81:119-43
pubmed: 22404626
EMBO J. 2012 May 30;31(11):2498-510
pubmed: 22505032
Curr Pharm Des. 2012;18(20):2883-90
pubmed: 22571657
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13799-804
pubmed: 22869755
Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7
pubmed: 22895430
PLoS One. 2012;7(8):e43223
pubmed: 22912832
Mol Cell Biol. 2012 Nov;32(22):4691-704
pubmed: 22988298
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Cell. 2012 Sep 28;151(1):56-67
pubmed: 23021215
J Biol Chem. 2012 Nov 9;287(46):38755-66
pubmed: 23027873
Nat Struct Mol Biol. 2012 Nov;19(11):1108-15
pubmed: 23064645
Nat Rev Drug Discov. 2012 Dec;11(12):892-4
pubmed: 23197022
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
Genes Cancer. 2012 Nov;3(11-12):731-8
pubmed: 23634260
Cell. 2013 Jun 6;153(6):1327-39
pubmed: 23746844
Transcription. 2013 Jul-Aug;4(4):146-52
pubmed: 23756342
Chem Rev. 2013 Nov 13;113(11):8491-522
pubmed: 23837720
Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):575-608
pubmed: 24088064
Br J Pharmacol. 2014 Jan;171(1):55-68
pubmed: 24102143
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Biochimie. 2014 Feb;97:22-7
pubmed: 24139904
Cancer Res. 2014 Jan 1;74(1):287-97
pubmed: 24240700
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Nat Commun. 2014 Mar 24;5:3505
pubmed: 24662513
Nat Struct Mol Biol. 2014 May;21(5):449-55
pubmed: 24704787
Mol Cell. 2014 May 22;54(4):601-12
pubmed: 24746699
Mol Cell. 2014 Jun 5;54(5):728-36
pubmed: 24905006
Nature. 2014 Jul 31;511(7511):616-20
pubmed: 25043025
Mol Cell Biol. 2014 Oct 1;34(19):3675-88
pubmed: 25047832
Genome Biol. 2014;15(6):122
pubmed: 25180339
Cell. 2014 Nov 20;159(5):1126-1139
pubmed: 25416950
Cancer Cell. 2014 Dec 8;26(6):909-922
pubmed: 25490451
Mol Cell Biol. 2015 Mar;35(6):928-38
pubmed: 25561469
Antimicrob Agents Chemother. 2015 Apr;59(4):2062-71
pubmed: 25624324
Nat Rev Drug Discov. 2015 Feb;14(2):130-46
pubmed: 25633797
J Med Chem. 2015 Feb 26;58(4):1717-35
pubmed: 25680029
Nucleic Acids Res. 2015 Mar 11;43(5):2575-89
pubmed: 25712099
J Biotechnol. 2015 May 20;202:40-9
pubmed: 25747275
Nat Struct Mol Biol. 2015 May;22(5):396-403
pubmed: 25849141
Nature. 2015 Apr 30;520(7549):697-701
pubmed: 25901683
Sci Rep. 2015 May 06;5:10120
pubmed: 25944566
Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1617-29
pubmed: 26006748
Chem Biol. 2015 Jun 18;22(6):755-63
pubmed: 26051217
Elife. 2015 Jun 17;4:e06535
pubmed: 26083714
Crit Rev Biochem Mol Biol. 2015;50(5):393-426
pubmed: 26182352
Biochim Biophys Acta. 2015 Sep;1849(9):1179-87
pubmed: 26189575
Mol Cell. 2015 Aug 20;59(4):576-87
pubmed: 26257281
Cell. 2015 Sep 24;163(1):28-30
pubmed: 26406367
Cell. 2015 Sep 24;163(1):174-86
pubmed: 26406377
Nature. 2015 Oct 8;526(7572):273-276
pubmed: 26416749
Cell Death Differ. 2016 Jun;23(6):1038-48
pubmed: 26658019
Science. 2015 Dec 11;350(6266):1383-6
pubmed: 26659056
Mol Cell. 2016 Jan 7;61(1):39-53
pubmed: 26725010
Genes Dev. 2016 Jan 1;30(1):117-31
pubmed: 26728557
PLoS One. 2016 Jan 08;11(1):e0146648
pubmed: 26745862
Cell Rep. 2016 Jan 12;14(2):320-31
pubmed: 26748711
J Med Chem. 2016 Feb 11;59(3):1078-101
pubmed: 26796641
Bioorg Med Chem Lett. 2016 Mar 1;26(5):1443-51
pubmed: 26852363
ACS Med Chem Lett. 2016 Jan 06;7(3):223-8
pubmed: 26985305
Cell Rep. 2016 Apr 12;15(2):436-50
pubmed: 27050516
Exp Mol Pathol. 2016 Jun;100(3):514-21
pubmed: 27155449
J Med Chem. 2016 Oct 13;59(19):8667-8684
pubmed: 27171036
Nature. 2016 May 25;534(7605):55-62
pubmed: 27251275
Clin Cancer Res. 2016 Dec 1;22(23):5929-5938
pubmed: 27301701
ACS Med Chem Lett. 2016 Mar 28;7(6):573-8
pubmed: 27326329
ACS Med Chem Lett. 2016 Apr 05;7(6):595-600
pubmed: 27326333
J Med Chem. 2016 Oct 27;59(20):9337-9349
pubmed: 27490956
Nat Chem Biol. 2016 Oct;12(10):876-84
pubmed: 27571479
Nat Struct Mol Biol. 2016 Sep 6;23(9):771-7
pubmed: 27605205
Crit Rev Biochem Mol Biol. 2016 Sep;51(5):395-411
pubmed: 27622638
Cancer Treat Rev. 2016 Nov;50:83-88
pubmed: 27662623
Mol Biosyst. 2017 Jan 31;13(2):246-276
pubmed: 27833949
Nat Rev Drug Discov. 2017 Feb;16(2):101-114
pubmed: 27885283
Elife. 2016 Dec 09;5:
pubmed: 27935476
Transcription. 2017 Mar 15;8(2):81-90
pubmed: 28005463
ChemMedChem. 2017 Mar 7;12(5):372-380
pubmed: 28125165
Nat Commun. 2017 Jan 30;8:14290
pubmed: 28134252
Oncotarget. 2017 Feb 21;8(8):12558-12575
pubmed: 28147342
Cell. 2017 Feb 9;168(4):629-643
pubmed: 28187285
Nat Rev Mol Cell Biol. 2017 Apr;18(4):263-273
pubmed: 28248323
Nucleic Acids Res. 2017 Jun 20;45(11):6698-6716
pubmed: 28334900
Mol Cell Biol. 2017 Jun 15;37(13):
pubmed: 28416637
Cancer Res. 2017 Jul 15;77(14):3834-3845
pubmed: 28455421
J Cell Biochem. 2018 Feb;119(2):1273-1284
pubmed: 28722178
Cell Rep. 2017 Aug 1;20(5):1173-1186
pubmed: 28768201
Nat Chem Biol. 2017 Oct;13(10):1102-1108
pubmed: 28805801
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10208-10213
pubmed: 28855340
ChemMedChem. 2017 Nov 8;12(21):1776-1793
pubmed: 28961375
Cell Rep. 2017 Oct 10;21(2):467-481
pubmed: 29020632
Cell Div. 2017 Oct 27;12:7
pubmed: 29090014
Cell Rep. 2017 Nov 7;21(6):1495-1506
pubmed: 29117556
Mol Cancer Ther. 2018 Jan;17(1):306-315
pubmed: 29133620
Oncotarget. 2017 Jun 21;8(49):84986-84995
pubmed: 29156698
Target Oncol. 2018 Feb;13(1):21-38
pubmed: 29218622
EBioMedicine. 2017 Dec;26:112-125
pubmed: 29239838
Nat Chem Biol. 2018 Feb;14(2):163-170
pubmed: 29251720
ChemMedChem. 2018 Feb 6;13(3):231-235
pubmed: 29266803
J Med Chem. 2018 Jun 28;61(12):5073-5092
pubmed: 29266937
Cancer Cell. 2018 Feb 12;33(2):202-216.e6
pubmed: 29358035
Trends Endocrinol Metab. 2018 May;29(5):281-282
pubmed: 29475579
Oncogene. 2018 May;37(20):2687-2701
pubmed: 29491412
Cell Res. 2018 Jun;28(6):690-692
pubmed: 29507396
Mol Cancer Ther. 2018 Jun;17(6):1156-1166
pubmed: 29545334
Protein Sci. 2018 Jun;27(6):1018-1037
pubmed: 29664212
Molecules. 2018 May 02;23(5):null
pubmed: 29724031
Nat Rev Mol Cell Biol. 2018 Jul;19(7):464-478
pubmed: 29740129
Cell. 2018 Jun 14;173(7):1770-1782.e14
pubmed: 29906450
ACS Med Chem Lett. 2018 Mar 18;9(6):540-545
pubmed: 29937979
Cell Rep. 2018 Jul 10;24(2):515-527
pubmed: 29996110
J Med Chem. 2018 Sep 13;61(17):7710-7728
pubmed: 30067358
J Biol Chem. 1995 May 26;270(21):12335-8
pubmed: 7759473
Genes Dev. 1996 Nov 1;10(21):2657-83
pubmed: 8946909
Genes Dev. 1997 Oct 15;11(20):2622-32
pubmed: 9334325
Genes Dev. 1997 Oct 15;11(20):2645-57
pubmed: 9334327
J Biol Chem. 1998 May 29;273(22):13855-60
pubmed: 9593731

Auteurs

Matthew D Galbraith (MD)

a Linda Crnic Institute for Down Syndrome, School of Medicine , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.
b Department of Pharmacology, School of Medicine , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.

Heather Bender (H)

a Linda Crnic Institute for Down Syndrome, School of Medicine , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.
b Department of Pharmacology, School of Medicine , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.

Joaquín M Espinosa (JM)

a Linda Crnic Institute for Down Syndrome, School of Medicine , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.
b Department of Pharmacology, School of Medicine , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.
c Department of Molecular, Cellular and Developmental Biology , University of Colorado Boulder , Boulder , CO , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH